Epibrassinolide Impaired Colon Tumor Progression and Induced Autophagy in SCID Mouse Xenograft Model via Acting on Cell Cycle Progression without Affecting Endoplasmic Reticulum Stress Observed In Vitro

Scientists evaluated the anti-tumoral effect of epibrassinolide as well as the autophagy involvement in the aggressive forms of colon cancer cell lines as well as in vivo SCID mouse xenograft colon cancer model for the first time.